Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Operating activities:
Net loss	$ (209,765)	$ (119,388)	$ (39,533)
Adjustments to reconcile net loss to net cash (used in) from operating activities:
Depreciation and amortization	24,854	26,044	26,188
Amortization of deferred loss (gain)	5	(261)	(1,214)
Amortization of deferred financing costs and debt discount	8,355	8,064	7,914
Impairment of Intangible Assets, Finite-lived	33,742	0	0
Impairment of goodwill	0	56,160	0
Non-cash write-down of Inventory	53,971	0	0
(Gain) loss on sale of property, plant & equipment	(21,568)	(5,603)	42
Unrealized (gains) losses on commodity hedges	(600)	(1,256)	358
Unrealized foreign currency transaction losses	5,385	3,540	0
Equity in losses (earnings) of joint venture	1,426	(7,691)	(6,987)
Dividends from joint venture	316	12,127	3,963
Pension Curtailment	2,923	0	0
Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements	3,915	0	0
Deferred income taxes	(23,842)	(19,094)	(27,436)
Share-based compensation expense	828	1,972	3,062
Excess tax benefits from share-based payment arrangements	0	(76)	(420)
Changes in assets and liabilities:
Accounts receivable	37,063	(5,785)	9,279
Inventories	63,986	(22,976)	96,234
Prepaid expenses and other current assets	(7,884)	(60)	1,402
Other non-current assets	(520)	1,686	1,470
Prepaid pension costs	2,675	387	3,953
Accounts payable	(4,461)	2,630	(434)
Accrued payroll and employee benefits	6,938	(230)	(1,892)
Income tax payable and receivable	2,083	(772)	4,388
Accrued Liabilities and Other Noncurrent Liabilities	(196)	(3,493)	(2,854)
Postretirement benefit obligations and other non-current liabilities	(1,762)	(1,002)	(3,098)
Net cash (used in) from operating activities	(22,133)	(75,077)	74,385
Investing activities:
Capital expenditures	(8,250)	(12,351)	(11,604)
Proceeds from Sale of Property, Plant, and Equipment	28,631	7,464	794
Net cash from (used in) investing activities	20,381	(4,887)	(10,810)
Financing activities:
Short-term debt repayments, net	0	0	(496)
Proceeds from long-term debt	967,035	462,404	115,300
Repayments of long-term debt	(960,962)	(403,811)	(170,345)
Payments of Build to Suit Liability	(500)	0	0
Payment of debt issue costs	0	(627)	0
Exercise of stock options	0	158	1,216
Excess tax benefits from share-based payment arrangements	0	76	420
Net cash from (used in) financing activities	5,573	58,200	(53,905)
Effect of exchange rate changes on cash and cash equivalents	(1,175)	(611)	(448)
Net change in cash and cash equivalents	2,646	(22,375)	9,222
Cash and cash equivalents—beginning of year	8,454	30,829	21,607
Cash and cash equivalents—end of year	$ 11,100	$ 8,454	$ 30,829